Collection-image

TOPICAL COLLECTIONS

Biofilms: Recent Advances in Control and Eradication

Submit Abstract

Guest Editor

Zvi Loewy

Zvi Loewy

Touro College of Pharmacy

Dr. Zvi Loewy is a senior academic leader and an experienced global pharmaceutical – biotechnology executive. He leverages a diversified background in big-pharma senior management, biotech startup creation and academia. Dr. Loewy has served as a board member of the New Jersey Bioscience Center Incubator since 2010. Dr. Loewy’s international experience has included leading international research teams; championing the penetration and commercial launch of healthcare products world-wide; and leading open innovation in the Mid-East. Dr. Loewy received his BA from Yeshiva University, his MS from Rensselaer Polytechnic Institute and his PhD in Molecular Biology from the Albert Einstein College of Medicine. Dr. Loewy has over 25 issued patents.

Collection Overview

The vast majority of cells in humans are of microbial origin. Microbial species harbored by humans include commensal as well as pathogenic organisms and are present either as planktonic cells or incorporated into biofilms. Pathogenic microbes, as components of biofilms can result in infections, and at times can initiate systemic diseases. The extracellular matrix encapsulating biofilms prevent conventional antimicrobials from functioning effectively. New approaches to characterize biofilms are being developed due to recent advancements in science and technology. These methods are proving to be key in studying the control and containment of pathogens. Characterization of biofilm structure and function coupled with a systems approach that includes conventional microbiology in concert with molecular analytical methodologies is being used to identify novel therapeutic interventions. This methods collection describes innovative techniques that are being used to identify and characterize emerging biological and chemical methods to control biofilms and eradicate pathogens.

Articles

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on <em>Candida tropicalis</em> Biofilms
6:50

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms

0 Views

•

Cited by 4

•

2022

•